Blackhawk Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-454
Closed -$226K 149
2025
Q1
$226K Buy
+454
New +$246K 0.12% 120
2022
Q1
Sell
-321
Closed -$214K 104
2021
Q4
$214K Buy
+321
New +$200K 0.13% 87
2018
Q3
Sell
-115
Closed -$24K 256
2018
Q2
$24K Hold
115
0.03% 214
2018
Q1
$24K Hold
115
0.02% 230
2017
Q4
$22K Buy
+115
New +$22K 0.02% 206

Other funds holding TMO

Blackhawk Capital Partners's TMO Position: Q2 2025 in Review

Blackhawk Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 454 shares — an estimated $226K sold.

Blackhawk Capital Partners first reported a position in TMO in Q4 2017 and held it in 5 quarters. The position peaked at $226K in Q1 2025. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Blackhawk Capital Partners reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Blackhawk Capital Partners sold 454 Thermo Fisher Scientific shares in Q2 2025, an estimated $226K.
  • Blackhawk Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 5 quarters.
  • Blackhawk Capital Partners's Thermo Fisher Scientific position peaked at $226K in Q1 2025.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Blackhawk Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.